Indie Asset Partners’s GSK GSK Stock Holding History

Indie Asset Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,960	Closed	-$270K	–	95
2022 Q2	$270K	Buy	4,960 +80	+2%	+$4.42K	0.24%	74
2022 Q1	$266K	Buy	4,880 +360	+8%	+$19.6K	0.2%	99
2021 Q4	$249K	Hold	4,520	–	–	0.18%	111
2021 Q3	$216K	Hold	4,520	–	–	0.17%	116
2021 Q2	$225K	Buy	+4,520	New	+$217K	0.18%	112
2020 Q3	–	Sell	-4,040	Closed	-$207K	–	98
2020 Q2	$207K	Buy	+4,040	New	+$207K	0.26%	88
2020 Q1	–	Sell	-4,230	Closed	-$248K	–	92
2019 Q4	$248K	Buy	+4,230	New	+$235K	0.26%	72

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Indie Asset Partners's GSK Position: Q3 2022 in Review

Indie Asset Partners sold out of GSK (GSK) in Q3 2022, closing a stake of 4,960 shares — an estimated $270K sold.

Indie Asset Partners first reported a position in GSK in Q4 2019 and held it in 7 quarters. The position peaked at $270K in Q2 2022. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Indie Asset Partners reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
Indie Asset Partners sold 4,960 GSK shares in Q3 2022, an estimated $270K.
Indie Asset Partners first reported a position in GSK in Q4 2019 and held it in 7 quarters.
Indie Asset Partners's GSK position peaked at $270K in Q2 2022.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Indie Asset Partners's 13F filing for Q3 2022, filed 25 Oct 2022.